MarketPeel
Insider Trading Intelligence
Pricing
…
AC

Andrew C. Chan

CRVS
DIRECTOR · CORVUS PHARMACEUTICALS, INC. · CIK 0002131504
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Apr 2026
HOLDINGS NOW
30,000
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Andrew C. Chan. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
30,000——30,000Apr 23, 2026Apr 27, 2026 ↗
Other insiders · CRVS
Loading peer insiders…
About this filer
CIK 0002131504
ROLE
Director
PRIMARY
CRVS
COMPANIES
1
ACTIVE SINCE
Apr 2026
MARKETPEEL · /INSIDER/0002131504DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback